Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630186PMC
http://dx.doi.org/10.1016/j.hrcr.2019.04.005DOI Listing

Publication Analysis

Top Keywords

sotalol load
8
outpatient intravenous
4
intravenous sotalol
4
load replace
4
replace 3-day
4
3-day admission
4
admission oral
4
oral sotalol
4
sotalol
2
load
2

Similar Publications

Article Synopsis
  • A study evaluated the use of intravenous (IV) sotalol for safely and quickly loading patients with atrial fibrillation, contrasting it with the traditional oral loading process that often requires a 3-day hospital stay.
  • The research involved 167 patients, mainly older adults, and found that 99% were admitted for sotalol initiation, achieving a short average hospital stay of 1.1 days with few adverse effects.
  • Results suggest that IV sotalol is a safe and efficient alternative for treating atrial arrhythmias; however, more research is necessary to determine the optimal hospital monitoring duration.
View Article and Find Full Text PDF
Article Synopsis
  • Wastewater-based epidemiology (WBE) is assessed for its reliability in estimating pharmaceutical consumption by comparing it to actual prescription data in urban areas.
  • Most pharmaceuticals, like ciprofloxacin and metoprolol, showed a minimal difference (below 0.2 order of magnitude) between WBE estimates and control values, indicating good reliability, especially for sedatives.
  • Seasonal patterns affected the load of specific drugs in the sewer system, but these changes did not significantly impact the reliability of WBE, suggesting it is a valid tool for estimating drug consumption despite some areas needing further research.
View Article and Find Full Text PDF

Background: Oral sotalol is a class III antiarrhythmic commonly used for the maintenance of sinus rhythm in patients with atrial fibrillation (AF). Recently, the Food and Drug Administration (FDA) approved the use of IV sotalol loading, based primarily on modeling data for the infusion. We aimed to describe a protocol and experience with IV sotalol loading for elective treatment of adult patients with AF and atrial flutter (AFL).

View Article and Find Full Text PDF

Introduction: Oral sotalol initiation requires a multiple-day, inpatient admission to monitor for QT prolongation during loading. A 1-day intravenous (IV) sotalol loading protocol was approved by the United States Food and Drug Administration in March 2020, but limited data on clinical use and administration currently exists. This study describes implementation of an IV sotalol protocol within an integrated health system, provides initial efficacy and safety outcomes, and examines length of stay (LOS) compared with oral sotalol initiation.

View Article and Find Full Text PDF

Background: Dose-dependent QT prolongation with class III antiarrhythmics mandates close monitoring often in an inpatient setting. Outpatient sotalol loading monitor provides an alternative to patients that is cost effective and allows preservation of hospital resources.

Objectives: The objectives for this study include assessing adverse events, assessing patient adherence to monitoring and follow-up, comparing hospital cost and resource utilization, and evaluating patient satisfaction with outpatient sotalol loading program.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!